Bone marrow transplants represent the first big treatment breakthrough in immunotherapy. One of Fred Hutchinson Cancer Research Center’s founders, Nobel laureate E. Donnall Thomas, MD, pioneered the technique through intensive experimentation in the 1960s and 70s. Since then, the transplant survival rate for patients with some blood cancers has gone from nearly zero to upwards of 85 percent. Today, the Fred Hutchinson Transplant Program at Seattle Cancer Care Alliance (SCCA) is the most experienced center in the world, having performed more than 14,000 bone marrow, peripheral blood stem cell, and cord blood transplants. Our success rates are also among the best, measured in terms of the one-year survival rates of our patients.
What to Expect
At SCCA, a transplant can be used to treat the following cancers: Acute and chronic leukemias, Hodgkin’s and non-Hodgkin’s lymphomas, myelodysplasia, and multiple myeloma. For complete information about the transplant program and what to expect, visit our bone marrow transplant section.